Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

The visit—Huang’s third to China this year—coincided with a series of significant developments: regulatory approval for ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

A terrific indication of AI’s promise is the 2024 Nobel Prize in chemistry, winners of which used AI to “crack the code” of ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...

Google, Meta, and CoreWeave lead an expected $90 billion wave of AI and energy investments in Pennsylvania, marking a shift ...

Healthcare product development is undergoing a major transformation, driven by technologies like AI, ML, and IoMT. These ...

The failure to enact a proposed 10-year moratorium on state AI regulations brings meaningful clarity for employers, according ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...